QTI vs. SRTS, INO, TELA, NSPR, MLSS, VANI, CTSO, ZYXI, EDAP, and APYX
Should you be buying QT Imaging stock or one of its competitors? The main competitors of QT Imaging include Sensus Healthcare (SRTS), Inovio Pharmaceuticals (INO), TELA Bio (TELA), InspireMD (NSPR), Milestone Scientific (MLSS), Vivani Medical (VANI), Cytosorbents (CTSO), Zynex (ZYXI), Edap Tms (EDAP), and Apyx Medical (APYX). These companies are all part of the "medical equipment" industry.
QT Imaging vs. Its Competitors
Sensus Healthcare (NASDAQ:SRTS) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, community ranking, media sentiment, risk, analyst recommendations, valuation and institutional ownership.
Sensus Healthcare has a net margin of 15.90% compared to QT Imaging's net margin of 0.00%. Sensus Healthcare's return on equity of 12.60% beat QT Imaging's return on equity.
In the previous week, Sensus Healthcare had 5 more articles in the media than QT Imaging. MarketBeat recorded 5 mentions for Sensus Healthcare and 0 mentions for QT Imaging. Sensus Healthcare's average media sentiment score of 1.29 beat QT Imaging's score of 0.00 indicating that Sensus Healthcare is being referred to more favorably in the media.
Sensus Healthcare has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.2, meaning that its share price is 120% less volatile than the S&P 500.
Sensus Healthcare has higher revenue and earnings than QT Imaging.
Sensus Healthcare presently has a consensus target price of $11.67, suggesting a potential upside of 134.74%. Given Sensus Healthcare's stronger consensus rating and higher possible upside, research analysts plainly believe Sensus Healthcare is more favorable than QT Imaging.
Sensus Healthcare received 187 more outperform votes than QT Imaging when rated by MarketBeat users.
25.3% of Sensus Healthcare shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 8.9% of Sensus Healthcare shares are owned by insiders. Comparatively, 75.4% of QT Imaging shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
Sensus Healthcare beats QT Imaging on 14 of the 16 factors compared between the two stocks.
Get QT Imaging News Delivered to You Automatically
Sign up to receive the latest news and ratings for QTI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding QTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
QT Imaging Competitors List
Related Companies and Tools
This page (NASDAQ:QTI) was last updated on 6/12/2025 by MarketBeat.com Staff
